Adjuvant Abraxane
by
Mark Levin
Since 1998, the standard of adjuvant care for patients with node-positive breast cancer in the United States and other parts of the world has been treatment with doxorubicin and cyclophosphamide followed ...
Read on »
Cervarix: Squalene Adjuvant Approved in US
by
Meryl Nass
... n who received Cervarix, FDA approved this new HPV vaccine from GlaxoSmithKline for the US market: the first-ever vaccine licensed in the US with a squalene-containing novel adjuvant, ASO3. Recall that only 10 months ago FDA was trying to figure out how to study the safety of these adjuvants. And FDA's chief scientist and head of the vaccine cen ...
Read on »
CDC Director Frieden: No Adjuvant
by
Meryl Nass
From today's Bloomberg News Kudos to Dr. Frieden, who said, perhaps in response to front page news that Novartis' (squalene-adjuvanted) swine flu vaccine would require only one dose (after initial testing in 100 subjects): “We don’t anticipate that we’ll be using adjuvanted vaccine in most of the s ...
Read on »
Adjuvant Avastin for breast cancer
by
Mark Levin
There is a great deal of interest in the adjuvant use of Avastin for breast cancer. FDA approved Avastin on 2/27/08 for first line treatment of metastatic cancer only. It is in several studies, including: A Study of ...
Read on »
Cervarix: Novel (but NOT Squalene-containing) Adjuvant Approved in US
by
Meryl Nass
... miscarriages in women who received Cervarix, FDA approved this new HPV vaccine from GlaxoSmithKline for the US market: the first-ever vaccine licensed in the US with a novel adjuvant, named ASO4. According to a GSK press release, "In clinical trials, the most common side effects after vaccination with CERVARIX included pain, redness and swelling, ...
Read on »
More Novel Adjuvants for the Swine Flu stockpile
by
Meryl Nass
HHS Purchases Additional H1N1 Vaccine Ingredients --July 13, 2009 (Thanks to Bloomberg News ) ManufacturerBulk VaccineAntigenBulk Virus Concentrate/FFFBulk Oil and Water AdjuvantSanofi Pasteur$61,425,00000GSK$00$71,400,000Novartis$346,334,4500$343,810,470CSL$000MedImmune$0$61,020,0000TOTAL$407,759,450$61,020,000$415,210,470 That means the Depa ...
Read on »
